The advances in targeting CD47/SIRPα “do not eat me” axis and their ongoing challenges as an anticancer therapy (IMAGE)

Impact Journals LLC

The advances in targeting CD47/SIRPα “do not eat me” axis and their ongoing challenges as an anticancer therapy

Caption

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Credit

Impact Journals, LLC

Usage Restrictions

Original content

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.